SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018How to do a systematic review- Matthew Law, BA (Hons), MSc, PhD & Joseph Tucker, MD, PhD, AMView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Getting involved in clinical research: from clinical trials to sub-studies- Nicholas Paton, MD, FRCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Research methodology- Matthew Law, BA (Hons), MSc, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Hep C: Country experience with elimination efforts- Vithurneat Hang, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Hep C: How we are going to get to hep C elimination from a clinician’s perspective- Gail Matthews, MBCHB, MRCP (UK), FRACP, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Introduction to immunology - What clinicians need to know- Paul Cameron, BMedSci, MBBS, PhD, FRACP, FRCPAView Slideset
DKDaniel KuritzkesMDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Broadly neutralizing antibodies for treatment and prevention of HIV-1- Daniel Kuritzkes, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Why we need KPLHS to end AIDS in the Asia Pacific- Michael Cassell, PhD, MEM, MAView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Sustainability of KPLHS through capacity building platform- Rangsima Airawanwat, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018KPLHS for same-day ART and differentiated service delivery in Thailand- Chamrong PhaengnongyangView Slideset
TLThuy LeMD, DPhilSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Con debater: IPT should be implemented for all HIV patientsin the Asia-Pacific- Thuy Le, MD, DPhilView Slideset
